Weiss Multi-Strategy Advisers’s Audentes Therapeutics, Inc BOLD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-122,833	Closed	-$7.35M	–	718
2019 Q4	$7.35M	Buy	+122,833	New	+$4.61M	0.12%	237

Weiss Multi-Strategy Advisers's BOLD Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 122,833 shares — an estimated $7.35M sold.

Weiss Multi-Strategy Advisers first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $7.35M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 122,833 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $7.35M.
Weiss Multi-Strategy Advisers first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Weiss Multi-Strategy Advisers's Audentes Therapeutics, Inc position peaked at $7.35M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.